These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3985888)

  • 1. Efficacy of phosphatidylcholine in the modulation of motion sickness susceptibility.
    Kohl RL; Ryan P; Homick JL
    Aviat Space Environ Med; 1985 Feb; 56(2):125-8. PubMed ID: 3985888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdermal scopolamine in the prevention of motion sickness: evaluation of the time course of efficacy.
    Homick JL; Kohl RL; Reschke MF; Degioanni J; Cintron-Trevino NM
    Aviat Space Environ Med; 1983 Nov; 54(11):994-1000. PubMed ID: 6651736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arousal and stability: the effects of five new sympathomimetic drugs suggest a new principle for the prevention of space motion sickness.
    Kohl RL; Calkins DS; Mandell AJ
    Aviat Space Environ Med; 1986 Feb; 57(2):137-43. PubMed ID: 3513752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there a role for nonsedating antihistamines in motion sickness? Fallout from space research may soon benefit your patients.
    Kohl RL
    J Respir Dis; 1991 Apr; 12(4 Suppl):S17-21. PubMed ID: 11542203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of divers in open water to motion sickness.
    Norfleet WT; Peterson RE; Hamilton RW; Olstad CS
    Undersea Biomed Res; 1992 Jan; 19(1):41-7. PubMed ID: 1536062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transderm scopolamine efficacy related to time of application prior to the onset of motion.
    Levy GD; Rapaport MH
    Aviat Space Environ Med; 1985 Jun; 56(6):591-3. PubMed ID: 4015572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrogastrograms during motion sickness in fasted and fed subjects.
    Stewart JJ; Wood MJ; Wood CD
    Aviat Space Environ Med; 1989 Mar; 60(3):214-7. PubMed ID: 2712799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of gender difference in motion sickness induced by vestibular Coriolis cross-coupling.
    Cheung B; Hofer K
    J Vestib Res; 2002-2003; 12(4):191-200. PubMed ID: 12897401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What you thought you knew about motion sickness isn't necessarily so.
    Cowings PS; Malmstrom FV
    Flying Saf; 1984 Feb; 40(2):12-7. PubMed ID: 11540877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of antimotion sickness drugs.
    Wood CD; Manno JE; Wood MJ; Manno BR; Redetzki HM
    Aviat Space Environ Med; 1987 Sep; 58(9 Pt 2):A262-5. PubMed ID: 3675502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The menstrual cycle and susceptibility to coriolis-induced sickness.
    Cheung B; Heskin R; Hofer K; Gagnon M
    J Vestib Res; 2001; 11(2):129-36. PubMed ID: 11847456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship of motion sickness susceptibility to learned autonomic control for symptom suppression.
    Cowings PS; Toscano WB
    Aviat Space Environ Med; 1982 Jun; 53(6):570-5. PubMed ID: 7115241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of direction of head movement on motion sickness caused by Coriolis stimulation.
    Woodman PD; Griffin MJ
    Aviat Space Environ Med; 1997 Feb; 68(2):93-8. PubMed ID: 9125096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of autogenic training and biofeedback on motion sickness tolerance.
    Jozsvai EE; Pigeau RA
    Aviat Space Environ Med; 1996 Oct; 67(10):963-8. PubMed ID: 9025819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of antimotion sickness drugs on habituation to motion.
    Wood CD; Manno JE; Manno BR; Odenheimer RC; Bairnsfather LE
    Aviat Space Environ Med; 1986 Jun; 57(6):539-42. PubMed ID: 3718377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effectiveness of the preparation Gavinton in preventing motion sickness].
    Bodo D; Kotovskaia AR; Galle RR; Gavrilova LN; Gusakova GA
    Kosm Biol Aviakosm Med; 1982; 16(3):49-51. PubMed ID: 7098411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Model of motion sickness in dogs for assessing the effectiveness of pharmacological substances].
    Radkevich LA
    Kosm Biol Aviakosm Med; 1977; 11(6):50-3. PubMed ID: 22775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of histaminergic drugs in experimental motion sickness.
    Matsnev EI; Sigaleva EE
    J Vestib Res; 2007; 17(5-6):313-21. PubMed ID: 18626141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histaminergic response to Coriolis stimulation: implication for transdermal scopolamine therapy of motion sickness.
    Wang ET; Zhou DR; He LH
    Aviat Space Environ Med; 1992 Jul; 63(7):579-82. PubMed ID: 1616432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing motion sickness: a comparison of autogenic-feedback training and an alternative cognitive task.
    Toscano WB; Cowings PS
    Aviat Space Environ Med; 1982 May; 53(5):449-53. PubMed ID: 7092752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.